News

One in three Americans is likely to be affected by a brain disorder in their lifetime. Many of these conditions, such as ...
There's a new type of AI bot on the block—and this time, it's completely autonomous. AI agents are steadily making their way ...
Immune system scientists and computational biologists are developing a new tool to investigate how the body fights disease.
These natural killer cells that develop immune memory are referred to as adaptive natural killer (aNK) cells. Scientists are working to understand more about these cell types and how they can be ...
This week, archaeologists identified depictions of the Milky Way galaxy in ancient Egyptian imagery. A mathematician found a ...
enzymatic conjugation platform that creates uniform and potent ADCs with high efficiency as Araris is focused on transforming cancer treatment by replacing traditional chemotherapy with targeted ...
The company, known for its work in developing cancer treatment drugs, is hoping to restructure. The company, which is based in Austin, TX, "listed $2.49 million in assets and $29.4 million in ...
If you’re not in great shape to start, you’re less likely to live as long as the average person, and you have less time to develop cancer in the first place. It’s quite likely that the ...
A three-dimensional (3D) printed artificial tumor tissue has emerged, capable of growing cancer cells derived from actual cancer patients in an environment that closely mimics in vivo conditions.
The study by Li et al. provides fundamental findings supported by convincing evidence that they defined cellular reprogramming of androgen receptor in neuroendocrine prostate cancer (NEPC). The ...
In episode 700 of Power Athlete Radio, I reflect on the blog post I wrote 10 years ago, 42 Things Learned, and the journey that inspired it. Revisiting the less ...